New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Cardium Therapeutics Inc (CXM)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Income Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
31-MAR
2012
30-JUN
2012
30-SEP
2012
31-DEC
2012
31-MAR
2013
Total Revenue
20.5K
13.2K
5589
746K
599K
Cost of Revenue
-52.0K
6096
3640
316K
258K
Gross Profit
72.5K
7078
1949
431K
341K
Research & Development
1.16M
425K
508K
524K
762K
SG&A
1.51M
1.46M
1.39M
1.76M
1.75M
Amortization & Deprec
57.5K
58.3K
58.4K
106K
92.5K
Other Expenses
-2539
-60.4K
-59.6K
6.36M
-217
Total Operating Expenses
2.73M
1.88M
1.90M
8.75M
2.60M
Operating Income
-2.66M
-1.87M
-1.89M
-8.32M
-2.26M
Other Income
64.2K
0
0
0
0
EBIT
-2.59M
-1.87M
-1.89M
-8.32M
-2.26M
Minority Interest
0
0
0
0
0
Interest Expense
1395
719
0
2134
910
Income Before Taxes
-2.59M
-1.88M
-1.89M
-8.32M
-2.26M
Income Taxes
0
0
0
0
0
Net Income from Continuing Ops
-2.59M
-1.88M
-1.89M
-8.32M
-2.26M
Income - Discontinued Ops
0
0
0
0
0
Extraordinary Items
0
0
0
0
0
Effect of Accounting Changes
0
0
0
0
0
Other Items
0
0
0
0
0
Net Income
-2.59M
-1.88M
-1.89M
-8.32M
-2.26M
Preferred Dividends
0
0
0
0
0
Net Income to Common
-2.59M
-1.88M
-1.89M
-1.96M
-2.26M
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour